Anterior chamber IOLs lasts longer

Article

Anterior chamber intraocular lenses (IOLs) last twice as long as posterior chamber IOLs, before they need to be replaced.

Anterior chamber intraocular lenses (IOLs) last twice as long as posterior chamber IOLs, before they need to be replaced, according to a study published in the February issue of the Journal of Cataract and Refractive Surgery.

Frederico F. Marques and colleagues from the Complexe Hospitalar Padre Bento de Guarulhos, Brazil, reviewed the outcomes of 49 subjects who had undergone IOL exchange between 1986 and 2002. Fifteen patients had been implanted with an anterior chamber IOL and 34 with a posterior chamber IOL.

The mean interval between first surgery and lens exchange was 83.2 months in the anterior chamber group and 37.9 months in the posterior chamber group. The main reason for exchange in the anterior chamber group was inflammation resulting from uveitis-glaucoma-hyphaema syndrome or persistent iritis. In contrast, posterior chamber IOLs were more likely to become decentred or dislocated.

Best corrected visual acuity (BCVA) in the anterior chamber group, after exchange, improved in nine eyes (60%), was stable in four (27%) and worsened in two (13%). In the posterior chamber group, BCVA imporved in 17 eyes (50%), was stable in 11 (32%) and worsened in six (18%).

The researchers concluded that anterior chamber IOLs are able to last twice as long as posterior chamber IOLs.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.